Search research articles
Contact Us
Filters
Showing results (111-120 of 663) with videos related to
Page
of 67
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)
|
August 11, 2012
The activity of the integrase inhibitor dolutegravir against HIV-1 variants isolated from raltegravir-treated adults
Mark R Underwood, Brian A Johns, Akihiko Sato, et al.
AIDS (London, England)
|
February 9, 2012
Association of tenofovir exposure with kidney disease risk in HIV infection
Rebecca Scherzer, Michelle Estrella, Yongmei Li, et al.
Plos Computational Biology
|
December 3, 2010
Treatment-mediated alterations in HIV fitness preserve CD4+ T cell counts but have minimal effects on viral load
Naveen K Vaidya, Libin Rong, Vincent C Marconi, et al.
Journal of Virology
|
January 26, 2007
Clinical resistance to enfuvirtide does not affect susceptibility of human immunodeficiency virus type 1 to other classes of entry inhibitors
Neelanjana Ray, Jessamina E Harrison, Leslie A Blackburn, et al.
The Journal of Infectious Diseases
|
May 2, 2003
T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy
Peter W Hunt, Jeffrey N Martin, Elizabeth Sinclair, et al.
Computational Statistics & Data Analysis
|
September 28, 2011
Two-way Bayesian hierarchical phylogenetic models: An application to the co-evolution of gp120 and gp41 during and after enfuvirtide treatment
Christina M R Kitchen, Jing Kroll, Daniel R Kuritzkes, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 21, 2018
Differential Expression of CD8<sup>+</sup> T Cell Cytotoxic Effector Molecules in Blood and Gastrointestinal Mucosa in HIV-1 Infection
Brenna E Kiniry, Peter W Hunt, Frederick M Hecht, et al.
The Journal of Infectious Diseases
|
February 6, 2018
Anti-Human Immunodeficiency Virus Antibodies in the Cerebrospinal Fluid: Evidence of Early Treatment Impact on Central Nervous System Reservoir?
Peter D Burbelo, Richard W Price, Lars Hagberg, et al.
AIDS Research and Therapy
|
September 3, 2014
Levels of circulating myeloid subpopulations and of heme oxygenase-1 do not predict CD4(+) T cell recovery after the initiation of antiretroviral therapy for HIV disease
Lillian Seu, Gabriel M Ortiz, Trevor D Burt, et al.
Plos One
|
December 5, 2012
Lack of evidence for mtDNA as a biomarker of innate immune activation in HIV infection
Adam S Lauring, Tzong-Hae Lee, Jeffrey N Martin, et al.
Page
of 67
Search research articles
Search
Showing results (111-120 of 663) with videos related to
Sort By:
Page
of 67
Journal of Acquired Immune Deficiency Syndromes (1999)
|
August 11, 2012
The activity of the integrase inhibitor dolutegravir against HIV-1 variants isolated from raltegravir-treated adults
Mark R Underwood, Brian A Johns, Akihiko Sato, et al.
AIDS (London, England)
|
February 9, 2012
Association of tenofovir exposure with kidney disease risk in HIV infection
Rebecca Scherzer, Michelle Estrella, Yongmei Li, et al.
Plos Computational Biology
|
December 3, 2010
Treatment-mediated alterations in HIV fitness preserve CD4+ T cell counts but have minimal effects on viral load
Naveen K Vaidya, Libin Rong, Vincent C Marconi, et al.
Journal of Virology
|
January 26, 2007
Clinical resistance to enfuvirtide does not affect susceptibility of human immunodeficiency virus type 1 to other classes of entry inhibitors
Neelanjana Ray, Jessamina E Harrison, Leslie A Blackburn, et al.
The Journal of Infectious Diseases
|
May 2, 2003
T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy
Peter W Hunt, Jeffrey N Martin, Elizabeth Sinclair, et al.
Computational Statistics & Data Analysis
|
September 28, 2011
Two-way Bayesian hierarchical phylogenetic models: An application to the co-evolution of gp120 and gp41 during and after enfuvirtide treatment
Christina M R Kitchen, Jing Kroll, Daniel R Kuritzkes, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 21, 2018
Differential Expression of CD8<sup>+</sup> T Cell Cytotoxic Effector Molecules in Blood and Gastrointestinal Mucosa in HIV-1 Infection
Brenna E Kiniry, Peter W Hunt, Frederick M Hecht, et al.
The Journal of Infectious Diseases
|
February 6, 2018
Anti-Human Immunodeficiency Virus Antibodies in the Cerebrospinal Fluid: Evidence of Early Treatment Impact on Central Nervous System Reservoir?
Peter D Burbelo, Richard W Price, Lars Hagberg, et al.
AIDS Research and Therapy
|
September 3, 2014
Levels of circulating myeloid subpopulations and of heme oxygenase-1 do not predict CD4(+) T cell recovery after the initiation of antiretroviral therapy for HIV disease
Lillian Seu, Gabriel M Ortiz, Trevor D Burt, et al.
Plos One
|
December 5, 2012
Lack of evidence for mtDNA as a biomarker of innate immune activation in HIV infection
Adam S Lauring, Tzong-Hae Lee, Jeffrey N Martin, et al.
Page
of 67